Solubility enhancement by Solvent deposition technique: An overview

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue SUPPL.4, 2012, Pages 15-19

  Jain, Sonam ^a   Sandhu, Premjeet ^a   Gurjar, Manisha ^a   Malvi, Reetesh ^b  

^a RGPV University Campus   (India)

^b Sagar Institute of Research and Technology   (India)

Author keywords

Carrier; Solid dispersion; Solvent deposition system; Superdisintegrants; Water insoluble drugs

Indexed keywords

ACETYLSALICYLIC ACID; ADSORBENT; CARBOXYMETHYLCELLULOSE; CHLORAMPHENICOL; CHLORDIAZEPOXIDE; DIGOXIN; DRUG CARRIER; DRUG SOLVENT; EXCIPIENT; FUROSEMIDE; GLIBENCLAMIDE; GRISEOFULVIN; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; ITRACONAZOLE; NIFEDIPINE; NITRENDIPINE; NORETHISTERONE; OXOLINIC ACID; PHENYLBUTAZONE; PIROXICAM; PREDNISOLONE; PREDNISONE; PROBUCOL; RESERPINE; STARCH GLYCOLATE SODIUM; SULFAETHIDOLE; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG ABSORPTION; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; HYDROPHILICITY; HYDROPHOBICITY; IN VIVO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; REVIEW; SCANNING ELECTRON MICROSCOPY; SOLVENT DEPOSITION; SURFACE PROPERTY; SUSTAINED RELEASE PREPARATION; TABLET DISINTEGRATION; TABLET FORMULATION; WETTABILITY; X RAY DIFFRACTION;

EID: 84874676156     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Johnson S.R., Zheng W. Recent progress in the computational prediction of aqueous solubility and absorption. AAPS Journal. 2006; 8:E27-E40.
2. Maas, J., Kamm W., Hauck G. An integrated early formulation strategy from hit evaluation to preclinical candidate profiling. Eur J Pharm Biopharm. 2007; 66:1-10.
3. Food and Drug Administration CDER, Guidance for industry: waiver for in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system, 2000.
4. Amidon G.L., Lennernaes H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995; 12:413-420.
5. Agarwal S., Gupta G.D., Chaudhary S. Solid dispersion as an eminent strategic approach in solubility enhancement of poorly soluble drugs. Int J Pharm Sci Res. 2010; 1:1-13.
6. Gothoskar A.V. Biopharmaceutical classification of drugs. Pharm Rev. 2005; 3:1. http://www.pharmainfo.net/reviews/biopharmaceutical-classification-drugs (accessed March 22, 2012).
7. Lipinski C.A. Avoiding investment in doomed drugs, is poor solubility an industry wide problem? Curr Drug Dis. 2001; 4:17-19.
8. Hellriegel E.T., Bjornsson T.D., Hauck W.W. Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies. Clin. Pharmacol Ther. 1996; 60: 601-607.
9. Ogunbona F.A., Smith I.F., Olawoye O.S. Fat contents of meals and bioavailability of griseofulvin in man. J Pharm Pharmacol. 1985; 37: 283-284.
10. Jamali F., Axelson J.F. Influence of metoclopramide and propantheline on GI absorption of griseofulvin in rats. J Pharm Sci. 1977; 66: 1540-1543.
11. Sekiguchi K., Obi N. Studies on absorption of eutectic mixture: I: A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull.1961; 9:866-872.
12. Sekiguchi K., Obi N., Ueda Y. Studies on absorption of eutectic mixture: II: Absorption of fused conglomerates of chloramphenicol and urea in rabbit. Chem Pharm Bull. 1964; 12:134-144.
13. Goldberg A.H., Gibaldi M., Kanig J.L. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures: II: Experimental evaluation of eutectic mixture: Urea-acetaminophen system. J Pharm Sci. 1966; 55:482-487.
14. Goldberg A.H., Gibaldi M., Kanig J.L. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures: III: Experimental evaluation of griseofulvin-succinic acid solution. J Pharm Sci. 1966; 55:487-492.
15. Chiou W.L., Riegelman S. Pharmaceutical application of solid dispersion system. J Pharm Sci. 1971; 60:1281-1302.
16. Vasanthavada, M., Tong, W., Serajuddin, A.T.M. (2008). Development of solid dispersion for poorly water-soluble drugs. In: R. Liu (2nd Ed.) Water-insoluble drug formulation (pp. 499-530). London: CRC Press.
17. Williams A.C., Timmins P., Lu M., Forbes R.T. Disorder and dissolution enhancement: Deposition of ibuprofen on to insoluble polymers. Eur J Pharm Sci. 2005; 26:288-294.
18. Fujii M., Okada H., Shibata Y., Teramachi H., Kondoh M., Watanabe Y. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int J Pharm. 2005; 293:145-153.
19. Serajuddin A.T.M. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems and recent breakthroughs. J Pharm Sci. 1999; 88:1058-1066.
20. Aguiar, A.J., Zelmer J.E., Kinkel A.W. Deaggregation behavior of a relatively insoluble substituted benzoic acid and its sodium salt. J Pharm Sci. 1967; 56:1243-1252.
21. Monkhouse D.C., Lach J.L. Use of adsorbents in enhancement of drug dissolution: I. J Pharm Sci. 1972; 61:1430-5.
22. Johnsen H., Moller N. Solvent deposition method for enhancement of dissolution rate: Importance of drug-to-excipient ratio. J Pharm Sci. 1978; 67:134-6.
23. Liao C., Jarowski C.I. Dissolution rates of corticoid solutions dispersed on silicas. J Pharm Sci. 1984; 73: 401-403.
24. Alsaidan S.M., Alsughayer A.A., Eshra A.G. Improved dissolution rate of indomethacin by adsorbents. Drug Dev Ind Pharm. 1998; 24:389-394.
25. Dastmalchi S., Barzegar-Jalali M. Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique. J Pharm Sci. 2005; 8:175-81.
26. Barzegar-Jalali M., Maleki N., Garjani A., Khandar A.A., Haji-Hosseinloo M., Jabbari R., Dastmalchi S. Enhancement of dissolution rate and anti-infammatory effects of piroxicam using solvent deposition technique. Drug Dev Ind Pharm. 2002; 28:681-686.
27. Cui F., Bengang Y. Comparison of methods to improve the dissolution rate of nitrendipine. Asian J Pharm Sci. 2008; 3:102-109.
28. Law S.L., Chiang C.H. Improving dissolution rates of griseofulvin by deposition on disintegrants. Drug Dev Ind Pharm. 1990; 16:137-147.
29. Chowdary K.P.R., Rao S.K.S. Investigation of dissolution enhancement of itraconazole by solid dispersion in superdisintegrants. Drug Dev Ind Pharm. 2000; 26:1207-1211.
30. Yen S.Y., Chen C.R., Lee M.T., Chen L.C. Investigation of dissolution enhancement of nifedipine by deposition on superdisintegrants. Drug Dev Ind Pharm. 1997; 23:313-317.
31. Chaulang G., Patel P., Hardikar S., Kelkar M. Formulation and evaluation of solid dispersions of furosemide in sodium starch glycolate. Trop J Pharm Res. 2009; 8:43-5.
32. Botzolakis J.E., Small L.E., and Augsburger L.L. Effect of disintegrants on drug dissolution from capsules filled on a dosator-type automatic capsule-filling machine. Int. J. Pharm., 12, 341 (1982).
33. Cui F.D., Yang M.S., You B., Fan Y. Preparation of sustained-release nitrendipine microspheres with Eudragit RS and Aerosil using quasi-emulsion solvent diffusion method. Int J Pharm. 2003; 259:103-13.
34. Cui F.D., Yang M.S., Jiang Y.Y. Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method. J Controlled release. 2003; 91:375-384.
35. Kakkar A.P., Gulati R., Bansal A.K. Solvent deposition of chlordiazepoxide on starch-lactose granules. Indian J Pharm Sci. 1993; 55(6): 212-217.